Antiarrhythmic Agents

Links shared publicly online about this topic

Forest acquires worldwide rights to novel antiarrhythmic agent azimilide

news-medical.net — “Forest Laboratories, Inc. today announced that its wholly-owned subsidiary Forest Laboratories Holdings Limited and Blue Ash Therapeutics, LLC have entered into an asset purchase agreement, pursuant to which Forest has acquired worldwide rights to azimilide, a novel antiarrhythmic agent originally developed by Procter & Gamble Pharmaceuticals.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on April 20, 2011 at 11:18 am By:

NewsMedical News-Medical.Net Health News

Forest acquires worldwide rights to novel antiarrhythmic agent azimilide: Forest Laboratories, Inc. today announ... http://bit.ly/hZ4o9k

10 months ago...

New antiarrhythmic dronedarone approved in Europe

theheart.org — “CORRECTED // The new antiarrhythmic agent dronedarone has been approved in the European Union and will be launched in its first markets there, in Germany and the UK, in the New Year.View full resource at theheart.org

  • View Related
  • Share

Most Recently Shared on December 1, 2009 at 1:10 pm By:

Cardiology Medical News about Anti-Arrhythmia Agents; Levosimendan

mdlinx.com — “Levosimendan - a calcium sensitising agent with potential anti-arrhythmic propertiesView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on June 23, 2010 at 7:24 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Levosimendan - a calcium sensitising agent with potential anti-arrhythmic properties: International... http://bit.ly/bNFyy4 #cardio #mdlinx

2 years ago...

Cardiology Medical News about Anti-Arrhythmia Agents

mdlinx.com — “New antiarrhythmic drugs for treatment of atrial fibrillationView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on April 7, 2010 at 6:28 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

New antiarrhythmic drugs for treatment of atrial fibrillation: The Lancet http://bit.ly/9T2AHd #cardio #mdlinx

2 years ago...

Dronedarone for AF seems safe in stable heart failure

theheart.org — “A post hoc analysis could help alleviate a lingering concern about the drug, which an FDA advisory panel recently recommended for approval.View full resource at theheart.org

  • View Related
  • Share

Most Recently Shared on May 16, 2009 at 12:30 pm By:

theheartorg Shelley Wood Cardiology

heartwire: ATHENA data suggest dronedarone for AF is safe in stable heart failure http://bit.ly/QumbE

3 years ago...

ATHENA published, FDA sets panel date for dronedarone in AF

theheart.org — “The drug is envisioned as a safer alternative to amiodarone in patients with atrial fibrillation. (Hohnloser SH et al. N Engl J Med 2009; 360:668-678.)View full resource at theheart.org

  • View Related
  • Share

Most Recently Shared on February 12, 2009 at 4:01 pm By:

theheartorg Shelley Wood Cardiology

ATHENA published, FDA readies to hear advisory panel on dronedarone for AF http://tinyurl.com/cn869q

3 years ago...

Safe, rapid transition from amiodarone to dronedarone

theheart.org — “Most patients, at least, who are in sinus rhythm after cardioversion from atrial fibrillation and for whom a transition from the old drug to the new one is planned can switch in two days. The post hoc analysis points to two signals that waiting longer might be safer, according to researchers.View full resource at theheart.org

  • View Related
  • Share

Most Recently Shared on March 15, 2010 at 12:44 pm By:

theheartorg Shelley Wood Cardiology

Safely switch from amiodarone to dronedarone in two days, suggests analysis: Most patients, at least, who ar... http://bit.ly/bjMk75 #ACC10

2 years ago...

Prism Pharmaceuticals Receives FDA Approval of Ready-to-Use Nexterone (Amiodarone HCl) Premixed Injection

drugs.com — “Nexterone (amiodarone HCl) is used to treat life-threatening ventricular fibrillation and ventricular tachycardia. Includes Nexterone side effects, interactions and indications.View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on November 22, 2010 at 9:51 pm By:

drugscom Drugs.com Health Site

FDA Approves Ready-to-Use Nexterone (Amiodarone HCl) Premixed Injection - http://bit.ly/eLpm0Y

1 year ago...

Prism Pharmaceuticals Receives FDA Approval of Ready-to-Use Nexterone (Amiodarone HCl) Premixed Injection

drugs.com — “Nexterone (amiodarone HCl) is used to treat life-threatening ventricular fibrillation and ventricular tachycardia. Includes Nexterone side effects, interactions and indications.View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on November 22, 2010 at 10:07 pm By:

Drugs_Devices Drugs and Devices OW OW Health

Prism Pharmaceuticals Receives FDA Approval of Ready-to-Use Nexterone (Amiodarone HCl) Premixed Injection:... http://bit.ly/e5xFxU #drug

1 year ago...

Dronedarone approved

theheart.org — “Dronedarone is envisioned as a safer alternative to amiodarone, a widely used antiarrhythmic agent in patients with AF.View full resource at theheart.org

  • View Related
  • Share

Most Recently Shared on July 2, 2009 at 4:35 pm By:

theheartorg Shelley Wood Cardiology

heartwire: FDA approves dronedarone for atrial fibrillation http://bit.ly/4eV82V

3 years ago...

YouTube - ESC Guidelines: Atrial fibrillation

youtube.com — “Update of the 2006 ACC/AHA/ESC guidelines and review the new aspects of medical therapy, whether anti-arrhythmic drugs or anti-thrombotic agents. An importan...View full resource at youtube.com

  • View Related
  • Share

Most Recently Shared on September 15, 2010 at 3:06 pm By:

escardio European Cardiology Cardiology and Medical Society

I uploaded a YouTube video -- ESC Guidelines: Atrial fibrillation http://youtu.be/pmYaXE-jpy0?a

1 year ago...

Baxter nabs Prism's arrythmia drug in $338M buyout - FierceBiotech

fiercebiotech.com — “Just months after gaining an FDA approval for ready-to-use IV formulations of its anti-arrhythmic agent Nexterone, Prism Pharmaceuticals has sealed a $338 million buyout deal with Baxter Read more...View full resource at fiercebiotech.com

  • View Related
  • Share

Most Recently Shared on April 18, 2011 at 3:20 pm By:

FierceBiotech FierceBiotech Health News

Baxter nabs Prism's arrythmia drug in $338M buyout. http://bit.ly/eijgEe

10 months ago...

Symposier - ESC Guidelines: Atrial fibrillation

symposier.com — “Uploaded and shared in Youtube by: escardiodotorg --" Update of the 2006 ACC/AHA/ESC guidelines and review the new aspects of medical therapy, whether anti-arrhythmic drugs or anti-thrombotic agents. An important place is given to ablation either via interventional techniques or surgery. Download the ESC guidelines on Atrial fibrillation: http://www.escardio.org/guidelines-surveys/esc-guidelines/Pages/atrial-fibrillation.aspxView full resource at symposier.com

  • View Related
  • Share

Most Recently Shared on December 7, 2010 at 5:25 am By:

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

  • NewsMedical

    News-Medical.Net

    Medical News from Around the World

    View Profile

  • theheartorg

    Shelley Wood

    Managing editor for heartwire on theheart.org--the most authoritative, balanced, and insightful cardiovascular disease news online. http://is.gd/nHJ4

    View Profile

  • MDLinx

    Sandeep Pulim MD

    Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry

    View Profile

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390